A neglected problem of developing countries: Noncystic fibrosis bronchiectasis


Babayigit A., Olmez D., UZUNER N., Cakmakci H., Tuncel T., KARAMAN Ö.

ANNALS OF THORACIC MEDICINE, vol.4, no.1, pp.21-24, 2009 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 4 Issue: 1
  • Publication Date: 2009
  • Doi Number: 10.4103/1817-1737.44781
  • Journal Name: ANNALS OF THORACIC MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.21-24
  • Keywords: Children, etiology, noncystic fibrosis bronchiectasis, CYSTIC-FIBROSIS, CHEST
  • Dokuz Eylül University Affiliated: Yes

Abstract

Background:Bronchiectasis has been defined as the abnormal and permanent dilation of the bronchi. It is still an important problem in many developing countries. Aim:The aim of this study was to identify the chacteristics and underlying etiology of children followed with the diagnosis of noncystic fibrosis bronchiectasis. Materials and Methods:Children with bronchiectasis confirmed with high-resolution computed tomography were enrolled into the study. The data of the patients, including symptoms of the disease, age at the onset of symptoms, findings of physical examination, labrotory investigations performed in order to identify the etiology of bronchiectasis, etiology of bronchiectasis if found, radiologic findings and treatment modalities were noted. Results: Sixty-six children between 1 and 17 years were included in the study retrospectively. Forty-four of them were males (66.7) and 22 (33.3) were females. The most common presenting symptoms were cough (100) and sputum expectoration (50). An underlying etiology was identified in 44 (66.7) of the study subjects. The four most common underlying causes were found as infections (21.2), asthma (16.7), aspiration syndromes and/or gastroesophageal reflux disease (9.1) and immunodeficiency syndromes (7.6), respectively. Conclusion:Identifying an underlying etiology will have a significant effect on the management of noncystic fibrosis bronchiectasis. Defining the cause of bronchiectasis may also decrease its incidence, progression and complications.